On December 12, Consun Pharma (01681) spent HKD 3.4373 million to repurchase 23,100 shares.
Kang Chen Pharmaceutical (01681) announced that on December 12, 2025, the company spent 3.4373 million Hong Kong dollars to repurchase 23.1 million shares, at a repurchase price of 14.76-14.97 Hong Kong dollars per share.
CONSUN PHARMA (01681) announced on December 12, 2025 that the company will spend 3.4373 million Hong Kong dollars to repurchase 23,100 shares at a price of 14.76-14.97 Hong Kong dollars per share.
Related Articles

Hefei Snowky Electric (001387.SZ) plans to invest 500 million yuan to build an electronic science and technology park and a high-end smart home industrial park in Hefei City.

HAOHAI BIOTEC (06826) plans to acquire approximately 19.8% of the equity of Jiangxi Ruiji Biological Engineering Technology Co., Ltd.

New Stocks News | It is rumored that Yinhe General has hired an investment bank to assist in its Hong Kong IPO, with the earliest filing expected in the first quarter of next year.
Hefei Snowky Electric (001387.SZ) plans to invest 500 million yuan to build an electronic science and technology park and a high-end smart home industrial park in Hefei City.

HAOHAI BIOTEC (06826) plans to acquire approximately 19.8% of the equity of Jiangxi Ruiji Biological Engineering Technology Co., Ltd.

New Stocks News | It is rumored that Yinhe General has hired an investment bank to assist in its Hong Kong IPO, with the earliest filing expected in the first quarter of next year.

RECOMMEND

Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025

Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025

Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025


